Drug Discovery Informatics Market is projected to value over USD 3.4 billion by 2027 end with a CAGR of over 9% during the forecast period 2020 to 2027.

The escalating expenditure on research and development, increased usage of informatics for discovering drugs and increased funding for research on rare and chronic diseases are some of the crucial factors responsible for the drug discovery informatics market growth. Conversely, a lack of skilled healthcare personnel and the steep cost of setting up the informatics software shall impede the market growth. 

Drug Discovery Informatics Market

Market Segmentation:

By Function
•    Sequencing and Target Data Analysis
•    Docking
•    Molecular Modeling
•    Library & Database Preparation
•    Other Functions      

By Application
•    Drug Discovery
•    Drug Development

By Solution
•    Software
•    Services

By End User
•    Pharmaceutical Companies
•    Biotechnology Companies
•    Contract Research Organizations 
•    Other End Users    

By Region
•    North America
•    Europe
•    Asia-Pacific
•    Latin America
•    Middle East and Africa

The market is categorised into function, application, solution, end user and region. The function segment is fragmented into sequencing and target data analysis, docking, molecular modelling, library and database preparation and other functions. The sequencing and target data analysis segment is predicted to hold the largest drug discovery informatics market share owing to a wide range of applications for sequencing analysis for new drugs and it is easy for handling information from different domains. The application segment is divided into drug discovery and drug development. The solutions segment is bifurcated into software and services. The end user segment is segregated into pharmaceutical companies, biotech companies, contract research organizations and other end users.

Regional Analysis:

The North America region is expected to dominate the market owing to advancements in drug discovery technology, increased research and development activities related to drug discovery and a strong presence of key market players in the region. 

Competitive Landscape:                            

The key players involved are Jubilant Life Sciences Limited, Charles River Laboratories, IBM, Clarivate Analytics, Accenture.

FutureWise Key Takeaways:

•    Growth prospects
•    SWOT analysis 
•    Key market trends 
•    Key data-points affecting market growth

Objectives of the Study:

•    To provide with an exhaustive analysis on the global drug discovery informatics market by function, by application, by solution, by end user and by region
•    To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
•    To evaluate and forecast micro-markets and the overall market 
•    To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
•    To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions      

Flexible Delivery Model:

•    We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
•    The customization Mobility Care offered are free of charge with purchase of any license of the report
•    You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com


Need Assistance


UK : +44 141 628 9353
US : +1 347 709 4931


Contact Sales

What you get

  • Excel Dataset

  • Infographics

  • PDF Report

  • Market Overview

  • PowerPoint Presentation

What's included

  • Consumer Perception and Procurement

  • Competitive Analysis

  • What’s Next

  • Market Data Forecast

  • Risks and Opportunity Assessment

  • Market Trends and Dynamics